Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Highlights and a hidden hazard - the FDA's new labeling regulations

Article Abstract:

The US Food and Drug Administration (FDA) is working to make the official descriptions of prescription drugs, known as package inserts or labeling, more helpful and user-friendly. However, along with these very modest alterations of drug labeling to be phased in over seven years beginning June 30, 2006, the changes include a provision that could severely limit the accountability of companies that fail to adequately evaluate or report the risks associated with their products.

Author: Avorn, Jerry, Shrank, William
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
Pharmaceutical industry, Labeling, United States. Food and Drug Administration

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Who should protect the public? The Supreme Court and medical device regulation

Article Abstract:

The Supreme Court's expected decision by June 2008, related to Charles Riegel versus Medtronic case is reviewed. The resolution could have great implication on government protection of consumers from the risks associated with medical devices and prescription drugs.

Author: Korobkin, Russell
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
Government domestic functions, Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors, Medical Instruments and Supplies, Medical Instruments & Equipment, Medical Equipment and Supplies Manufacturing, Medical Instruments & Supplies, Consumer Protection Laws, Company legal issue, Consumer protection, Investigations, Medical equipment, Medical equipment and supplies industry, Medical equipment industry, United States. Supreme Court, Medical test kit industry, Health policy, Physiological apparatus, Medtronic Bio-Medicus Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Drugs, Laws, regulations and rules, Government regulation
Similar abstracts:
  • Abstracts: Immigrants are a positive part of the NHS. We should be open about resuscitation
  • Abstracts: Clinical research and the NIH -- a report card. Public registration of clinical trials. Clinical research to clinical practice -- lost in translation?
  • Abstracts: Giant-cell arteritis and polymyalgia rheumatica. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis
  • Abstracts: Healthier working lives across the UK. Putting on gloves. Gaining patient consent for blood tests following sharps injuries
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.